These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37425717)

  • 21. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.
    Fan Y; Lu H; Guo Y; Zhu T; Garcia-Barrio MT; Jiang Z; Willer CJ; Zhang J; Chen YE
    Gastroenterology; 2016 May; 150(5):1208-1218. PubMed ID: 26774178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel association of
    Kim DS; Jackson AU; Li YK; Stringham HM; Kuusisto J; Kangas AJ; Soininen P; Ala-Korpela M; Burant CF; Salomaa V; Boehnke M; Laakso M; Speliotes EK
    J Lipid Res; 2017 Jul; 58(7):1471-1481. PubMed ID: 28539357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes sex-specific effects associated with E167K coding variant in
    Fan Y; Wolford BN; Lu H; Liang W; Sun J; Zhou W; Rom O; Mahajan A; Surakka I; Graham SE; Liu Z; Kim H; Ramdas S; Fritsche LG; Nielsen JB; Gabrielsen ME; Hveem K; Yang D; Song J; Garcia-Barrio MT; Zhang J; Liu W; Zhang K; Willer CJ; Chen YE
    iScience; 2021 Nov; 24(11):103196. PubMed ID: 34746691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbation of
    Pant A; Chen Y; Kuppa A; Du X; Halligan BD; Speliotes EK
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.
    Liu Z; Que S; Zhou L; Zheng S; Romeo S; Mardinoglu A; Valenti L
    Sci Rep; 2017 Aug; 7(1):9273. PubMed ID: 28839198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.
    Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E
    Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease.
    Chen LZ; Xia HH; Xin YN; Lin ZH; Xuan SY
    J Clin Transl Hepatol; 2015 Dec; 3(4):265-70. PubMed ID: 26807382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.
    Milano M; Aghemo A; Mancina RM; Fischer J; Dongiovanni P; De Nicola S; Fracanzani AL; D'Ambrosio R; Maggioni M; De Francesco R; Fargion S; Berg T; Stickel F; Hampe J; Romeo S; Colombo M; Valenti L
    Hepatology; 2015 Jul; 62(1):111-7. PubMed ID: 25820484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms.
    Wu X; Sakata N; Dixon J; Ginsberg HN
    J Lipid Res; 1994 Jul; 35(7):1200-10. PubMed ID: 7964181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
    Kozlitina J; Smagris E; Stender S; Nordestgaard BG; Zhou HH; Tybjærg-Hansen A; Vogt TF; Hobbs HH; Cohen JC
    Nat Genet; 2014 Apr; 46(4):352-6. PubMed ID: 24531328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.
    Eslam M; Mangia A; Berg T; Chan HL; Irving WL; Dore GJ; Abate ML; Bugianesi E; Adams LA; Najim MA; Miele L; Weltman M; Mollison L; Cheng W; Riordan S; Fischer J; Romero-Gomez M; Spengler U; Nattermann J; Rahme A; Sheridan D; Booth DR; McLeod D; Powell E; Liddle C; Douglas MW; van der Poorten D; George J;
    Hepatology; 2016 Jul; 64(1):34-46. PubMed ID: 26822232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion.
    Chung S; Gebre AK; Seo J; Shelness GS; Parks JS
    J Lipid Res; 2010 Apr; 51(4):729-42. PubMed ID: 20215580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate diet-induced changes in very low density lipoprotein composition and structure.
    Witztum JL; Schonfeld G
    Diabetes; 1978 Dec; 27(12):1215-29. PubMed ID: 214369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
    Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
    J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol.
    Fungwe TV; Cagen L; Wilcox HG; Heimberg M
    J Lipid Res; 1992 Feb; 33(2):179-91. PubMed ID: 1569371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
    Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
    Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles.
    Werner A; Havinga R; Bos T; Bloks VW; Kuipers F; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1150-8. PubMed ID: 15662048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids.
    Prill S; Caddeo A; Baselli G; Jamialahmadi O; Dongiovanni P; Rametta R; Kanebratt KP; Pujia A; Pingitore P; Mancina RM; Lindén D; Whatling C; Janefeldt A; Kozyra M; Ingelman-Sundberg M; Valenti L; Andersson TB; Romeo S
    Sci Rep; 2019 Aug; 9(1):11585. PubMed ID: 31406127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Boyer A; Park SB; de Boer YS; Li Q; Liang TJ
    Gastroenterology; 2018 Dec; 155(6):1923-1935.e8. PubMed ID: 30144428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.